EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utilization of Native CRISPR-Cas9 System for Expression of Glucagon-like Peptide-1 in Lacticaseibacillus paracasei

Mumin Zheng, Shuwen Zhang, Yunna Wang, Ning Xie, Xiaodan Wang, Jiaping Lv, Xiaoyang Pang iD, Xu Li

Foods · 17.05.2025 · 14 (10) · 1785

DOI: 10.3390/foods14101785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Foods, online erschienen am 17.05.2025. Verfasst von Mumin Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Agro-Products Quality and Safety Control in Storage and Transport Process, Ministry of Agriculture and Rural Affairs, Institute of …. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Dairy Industry Technology System, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes is one of the main causes of cardiovascular diseases, kidney diseases, and visual impairments, posing a global healthcare challenge. The current treatment of this disease, involving glucagon-like peptide-1 (GLP-1), is faced with problems such as frequent injections and plasmid instability. In this study, we used the native clustered regularly interspaced short palindromic repeats-CRISPR-associated protein 9 (CRISPR-Cas9) system of Lacticaseibacillus paracasei to develop a novel, genetically stable, and orally administrable strain expressing human GLP-1. Integration and subsequent expression of glp-1 gene were confirmed by genomic sequencing, qPCR, and Nano LC-MS. The engineered strain demonstrated stable genomic integration and sustained high-level expression of GLP-1 over multiple generations. This innovative approach provides a promising strategy for the oral delivery of therapeutic peptides, potentially enhancing patient compliance and improving the treatment of diabetes and other chronic diseases requiring peptide-based therapies.

Schlagwörter

Stichwörter der Autor:innen

Lacticaseibacillus paracaseigenome editingglucagon-like peptide-1 (GLP-1)heterologous expressionnative CRISPR-Cas9

Autor:innen und Institutionen

  • Key Laboratory of Agro-Products Quality and Safety Control in Storage and Transport Process, Ministry of Agriculture and Rural Affairs, Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences,…

ORCID-Profile: Xiaoyang Pang

Förderung

  • National Natural Science Foundation of China
  • National Dairy Industry Technology System
  • Beijing Natural Science Foundation
  • Agricultural Science and Technology Innovation Program of Institute of Food Science and Tech-nology, CAAS
  • Xinjiang Key R&D Programme Projects
  • Key R&D Project of Karamay
  • Agricultural Science and Technology Innovation Program of Institute of Food Science and Technology, CAAS
  • Xinjiang Key R&D Programme Projects

Zitieren

APA

Zheng, M., Zhang, S., Wang, Y., Xie, N., Wang, X., Lv, J., Pang, X., & Li, X. (2025). Utilization of Native CRISPR-Cas9 System for Expression of Glucagon-like Peptide-1 in Lacticaseibacillus paracasei. Foods, 14(10), 1785. https://doi.org/10.3390/foods14101785

Vancouver

Zheng M, Zhang S, Wang Y, Xie N, Wang X, Lv J, et al. Utilization of Native CRISPR-Cas9 System for Expression of Glucagon-like Peptide-1 in Lacticaseibacillus paracasei. Foods. 2025;14(10):1785. doi:10.3390/foods14101785

BibTeX
@article{Zheng2025,
  author = {Zheng, Mumin and Zhang, Shuwen and Wang, Yunna and Xie, Ning and Wang, Xiaodan and Lv, Jiaping and Pang, Xiaoyang and Li, Xu},
  title = {Utilization of Native CRISPR-Cas9 System for Expression of Glucagon-like Peptide-1 in Lacticaseibacillus paracasei},
  journal = {Foods},
  year = {2025},
  volume = {14},
  number = {10},
  pages = {1785},
  doi = {10.3390/foods14101785}
}
Kostenlos starten →